| ULTRAGENYX PHARM. DL-,001 |
| USA |
| Gesundheit |
| US90400D1081 / A1XCY0 |
| UP0 (Frankfurt) / RARE (NASDAQ) |
| FRA:UP0, ETR:UP0, UP0:GR, NASDAQ:RARE |
| - |
| https://www.ultragenyx.co.. |
|
Ultragenyx Pharmaceutical Inc. is a biopharmaceuti..
>Volltext.. |
| 2807.18 Mio. EUR |
| 3141.84 Mio. EUR |
| 531.02 Mio. EUR |
| -408.73 Mio. EUR |
| -463.81 Mio. EUR |
| -4.81 EUR |
| 768.39 Mio. EUR |
| 161.3 Mio. EUR |
| -366.61 Mio. EUR |
| 1.69 |
| 15.27% |
| 17.18% |
| - |
| - |
| - |
| ULTRAGENYX |
| 05.11.25 |